Business Wire

Tandem Diabetes Care Announces FDA Approval of t:slim X2 Insulin Pump with Basal-IQ Technology

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced ...
Seeking Alpha

Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control-IQ automated ...
Nasdaq

Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor

Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...
Hosted on MSN

Tandem secures approval for t:slim X2 insulin pump to use with Lyumjev

Tandem Diabetes Care has announced that its t:slim X2 insulin pump, featuring Control-IQ automated insulin delivery technology, received approval for use with the ultra-rapid-acting insulin, Lyumjev ...
Seeking Alpha

Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada

“The commercial availability of this new offering is a testament to our decade-long partnership with Dexcom and shared commitment to continued leadership in advancing AID systems,” said Mark Novara, ...
Medscape

Tandem Insulin Pump System Integrates With Libre Sensor

Tandem Diabetes Care's t:slim X2 Insulin Pump Automated Insulin Delivery System is now the first to incorporate the Abbott FreeStyle Libre 2 Plus Sensor for users in the United States. The FreeStyle ...
The American Journal of Managed Care

T:Slim X2 Insulin Pump Use Safe in Pregnant Individuals With T1D, but Efficacy Varies

The pump had varying success in reaching recommended glycemic targets among the study participants with type 1 diabetes (T1D). T1D has been associated with an increased rate of adverse outcomes during ...
Medscape

Tandem Recall Urges Updating App Used With Insulin Pump

The US Food and Drug Administration (FDA) has announced that Tandem Diabetes Care, Inc has issued a recall regarding version 2.7 of the Apple iOS t:connect mobile app that is used in conjunction with ...
Business Wire

Data Presented at International Diabetes Conference Further Demonstrate Benefits of Tandem Diabetes Care Automated Insulin Delivery Technologies

MADRID--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, announced positive data presented today on its automated insulin ...
FierceBiotech

Dexcom’s G7 CGM links up with Tandem Diabetes’ t:slim X2 insulin pump

It takes two: After making its commercial debut early this year, Dexcom’s latest continuous glucose monitor is wrapping up 2023 by connecting with its first automated insulin pump partner, courtesy of ...
FierceBiotech

Tandem kicks off wider US launch of miniaturized Mobi insulin pump

After a successful limited rollout of its newest insulin pump in the U.S., Tandem Diabetes Care is picking up the pace. The Mobi pump will now begin a widespread national launch, with Tandem already ...